FR2420974A1 - Medicament a base de derives de l'uracile - Google Patents

Medicament a base de derives de l'uracile

Info

Publication number
FR2420974A1
FR2420974A1 FR7907523A FR7907523A FR2420974A1 FR 2420974 A1 FR2420974 A1 FR 2420974A1 FR 7907523 A FR7907523 A FR 7907523A FR 7907523 A FR7907523 A FR 7907523A FR 2420974 A1 FR2420974 A1 FR 2420974A1
Authority
FR
France
Prior art keywords
uracil
derivative
fluoro
medicine based
uracil derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7907523A
Other languages
English (en)
Other versions
FR2420974B1 (fr
Inventor
Setruro Fujii
Norio Unemi
Setsuo Takeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3583478A external-priority patent/JPS54129131A/ja
Priority claimed from JP9281378A external-priority patent/JPS5519245A/ja
Priority claimed from JP13768678A external-priority patent/JPS5564518A/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of FR2420974A1 publication Critical patent/FR2420974A1/fr
Application granted granted Critical
Publication of FR2420974B1 publication Critical patent/FR2420974B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention a pour objet un nouveau médicament Ce médicament comprend une association d'un dérivé du 5-fluoro-uracile, qui peut être le 5-fluoro-uracile lui-même, avec un dérivé de l'uracile qui peut être par exemple la cytosine, la cytidine, ou la 2'-déaoxycytidine. Il peut être utilisé pour le traitement de cancers. Dans ces compositions médicamenteuses, le 5-fluoro-uracile actif, qui se forme par décomposition de son dérivé dans le métabolisme, n'est pas détruit avant l'arrivée aux tissus cancéreux où il exerce son action, grâce à la présence du dérivé de l'uracile.
FR7907523A 1978-03-27 1979-03-26 Medicament a base de derives de l'uracile Granted FR2420974A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3583478A JPS54129131A (en) 1978-03-27 1978-03-27 Antiimalignant tumor agent composition
JP9281378A JPS5519245A (en) 1978-07-28 1978-07-28 Anti-malignant tumor agent composition
JP13768678A JPS5564518A (en) 1978-11-07 1978-11-07 Carcinostatic composition

Publications (2)

Publication Number Publication Date
FR2420974A1 true FR2420974A1 (fr) 1979-10-26
FR2420974B1 FR2420974B1 (fr) 1983-06-24

Family

ID=27288895

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7907523A Granted FR2420974A1 (fr) 1978-03-27 1979-03-26 Medicament a base de derives de l'uracile

Country Status (6)

Country Link
US (2) US4650801A (fr)
CH (1) CH639274A5 (fr)
DE (1) DE2912112C2 (fr)
FR (1) FR2420974A1 (fr)
GB (1) GB2016921B (fr)
IT (1) IT1119283B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59083A (en) * 1979-01-10 1983-12-30 Israel Marcus Pharmaceutical composition containing thymidine and a salicyclic acid derivative as a solubilizing agent therefor
JPS5735516A (en) * 1980-08-11 1982-02-26 Yamasa Shoyu Co Ltd Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
CA1227794A (fr) * 1983-05-23 1987-10-06 Jun-Ichi Yamashita Derives de substitution 2'-desoxy-5- de l'uridine; methode de preparation et agent anti-tumeurs qui en renferme
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
NL8700366A (nl) * 1987-02-13 1988-09-01 Stichting Rega V Z W Combinatie van fu met bvdu als middel tegen adenocarcinoom.
AU644684B2 (en) * 1990-09-07 1993-12-16 Taiho Pharmaceutical Co., Ltd. Antineoplastic effect potentiator and antineoplastic agent
AU8388198A (en) * 1997-08-21 1999-03-08 Basf Aktiengesellschaft Use of uridine to counter 5-fluorouracil toxicity
JPH11116564A (ja) * 1997-10-09 1999-04-27 Otsuka Chem Co Ltd クロモン誘導体
US6005098A (en) * 1998-02-06 1999-12-21 Hoffmann-La Roche Inc. 5'deoxycytidine derivatives
US20030134003A1 (en) * 2001-10-09 2003-07-17 Medigreen Biotechnology Inc. Method of using geranium oil and sophora root extracts as a supporting composition in cancer treatments
CN102014900B (zh) * 2008-03-11 2014-04-02 大学健康网络 一种神经肽y5r(npy5r)拮抗剂在制备治疗癌症的药物中的应用
ITMI20120921A1 (it) 2012-05-28 2013-11-29 Fond Istituto Italiano Di Tec Nologia 45 Inibitori della ceramidasi acida e loro usi come medicamenti

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2386310A1 (fr) * 1977-04-05 1978-11-03 Taiho Pharmaceutical Co Ltd Medicament comprenant une association d'uracile et d'un 5-fluoro-uracile

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481203A (en) * 1977-04-05 1984-11-06 Taiho Pharmaceutical Company, Limited Composition containing 1-(n-hexylcarbamoyl)-5-fluorouracil and uracil
US4328229A (en) * 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
JPS5735516A (en) * 1980-08-11 1982-02-26 Yamasa Shoyu Co Ltd Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
JPS5767518A (en) * 1980-09-17 1982-04-24 Yamasa Shoyu Co Ltd Radiosensitizing agent or agent for increasing effect of radiomimetic substance

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2386310A1 (fr) * 1977-04-05 1978-11-03 Taiho Pharmaceutical Co Ltd Medicament comprenant une association d'uracile et d'un 5-fluoro-uracile

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1978 *
EXBK/72 *

Also Published As

Publication number Publication date
IT7967629A0 (it) 1979-03-27
US4650801A (en) 1987-03-17
GB2016921B (en) 1982-08-18
IT1119283B (it) 1986-03-10
CH639274A5 (de) 1983-11-15
DE2912112A1 (de) 1979-10-11
DE2912112C2 (de) 1983-05-26
GB2016921A (en) 1979-10-03
US4914105A (en) 1990-04-03
FR2420974B1 (fr) 1983-06-24

Similar Documents

Publication Publication Date Title
FR2420974A1 (fr) Medicament a base de derives de l'uracile
FR2400904A1 (fr) Preparations pour administration vaginale et leur utilisation comme agents provoquant l'ovulation ou comme agents anti-mitotiques
EA200000718A1 (ru) Композиции целекоксиба
KR950700060A (ko) 운동 뉴우런 질병의 치료에 유용한 약품을 얻기 위한 2-아미노-6-트리플루오로메톡시 벤조티아졸(리루졸)의 사용(Application of 2-amino 6-trifluoromethoxy benzothiazole(riluzole) for obtaining a drug useful in the treatment of motor neuron diseases)
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
KR930702002A (ko) 아폽토시스 조정제
BE899564A (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation.
KR950000663A (ko) 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질
FR2381525A1 (fr) Compositions pharmaceutiques antioestrogenes
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
BE901301A (fr) 5-pyrimidine-carboxamides et thiocarboamides, ainsi que le traitement de la leucemie et des tumeurs avec ces substances.
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
FR2376660A1 (fr) Medicament a base d'alkannine, de shikonine ou de derives de ces substances, soignant les lesions cutanees de diverses origines
FR2393579A1 (fr) Agent antiviral et son application au traitement des affections virales
FR2375865A1 (fr) Compositions medicamenteuses contenant des sterolines et leurs applications therapeutiques
FR2397425A1 (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
KR880013927A (ko) 피리미딘 유도체
Hunskaar A case of ecthyma contagiosum (human orf) treated with idoxuridine
FR2507605B1 (fr) Procede de preparation d'esters d'acides apovincaminiques, esters ainsi obtenus et compositions pharmaceutiques preparees avec ces esters
BE1002182A5 (fr) Compositions pharmaceutiques.
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant
BE867634A (fr) Composes de la serie des pregnanes avec une fonction oxygene en position 19, procede de preparation et preparations pharmaceutiques qui contiennent ces composes
KR880004810A (ko) 소화성 궤양 치료제
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
FR2389378A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse